Therapeutic Classification: anti-Alzheimers's agents
Pharmacologic Classification: n methyl d aspartate antagonist
Absorption: Well absorbed after oral administration.
Distribution: Unknown.
Metabolism/Excretion: 57–82% excreted unchanged in urine by active tubular secretion moderated by pH dependent tubular reabsorption. Remainder metabolized; metabolites are not pharmacologically active.
Half-life: 60–80 hr.
Contraindicated in:
Use Cautiously in:
CV: hypertension.
Derm: rash.
GI: diarrhea.
GU: urinary frequency.
Hemat: anemia.
Metab: weight gain.
Neuro: dizziness, fatigue, headache, sedation.
Drug-Drug:
Renal Impairment
(Generic available)
NDC Code*